HAROUSSEAU JEAN-LUC ET AL: "Multiple myeloma.", HEMATOLOGY / THE EDUCATION PROGRAM OF THE AMERICAN SOCIETY OF HEMATOLOGY. AMERICAN SOCIETY OF HEMATOLOGY. EDUCATION PROGRAM 2004 LNKD- PUBMED:15561686, 2004, pages 237-256, ISSN: 1520-4391 (B1)

MULIVOR A W ET AL: "RAP-011, a soluble activin receptor type IIA murine IgG-Fc fusion protein, is a novel bone anabolic agent that prevents bone loss and skeletal metastases in a mouse model of metastatic breast cancer", BONE, PERGAMON PRESS., OXFORD, GB, vol. 44, 1 June 2009 (2009-06-01), pages S221-S222, XP026136471, ISSN: 8756-3282, DOI: 10.1016/J.BONE.2009.03.066 [retrieved on 2009-05-23] (B1)

N. RAJE ET AL: 'Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma' CLINICAL CANCER RESEARCH vol. 17, no. 6, 15 March 2011, pages 1278 - 1286, XP055006243 ISSN: 1078-0432 (B1)

PEARSALL, R. SCOOTET AL: "A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity" PNAS, vol. 105, no. 19, 13 May 2008 (2008-05-13), pages 7082-7087, XP002494788 (B1)

S. VALLET ET AL: 'From the Cover: Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease' PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES vol. 107, no. 11, 16 March 2010, pages 5124 - 5129, XP055006239 ISSN: 0027-8424 (B1)

WO-A-2007/062188 (B1)

SAKAI R ET AL: "Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats" BONE, PERGAMON PRESS., OXFORD, GB, vol. 27, no. 1, 1 July 2000 (2000-07-01), pages 91-96, XP002294252 ISSN: 8756-3282 (B1)

US-A1- 2006 068 468 (B1)

US-A1- 2007 249 022 (B1)

WO-A-2005/094871 (B1)

WO-A-2006/012627 (B1)

SAKAI ET AL.: "Activin release from bone coupled to bone resorption in organ culture of neonatal mouse calvaria" BONE, vol. 26, no. 3, 2000, pages 235-240, XP009105409 (B1)